Watchlist Price Alert

Keros Therapeutics Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

13.45

0.04 (0.30%)

At close: Jul 03, 2025, 2:59 PM

Keros Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-187.35M	-152.99M	-104.68M	-58.74M	-45.36M	-12.34M	-1.33M
Depreciation & Amortization	1.23M	815K	674K	378K	278K	208K	153K
Stock-Based Compensation	34.87M	28.76M	18.68M	11.72M	4.1M	59K	81K
Other Working Capital	-8.59M	384K	-3.28M	-597K	2.21M	-8.04M	7.95M
Other Non-Cash Items	1.82M	1.56M	953K	520K	1.82M	2.79M	194K
Deferred Income Tax	n/a	n/a	n/a	46K	n/a	n/a	n/a
Change in Working Capital	-11.44M	-2.65M	14.31M	-16.07M	2.27M	-6.72M	7.95M
Operating Cash Flow	-160.87M	-124.51M	-70.06M	-62.15M	-36.89M	-16M	7.04M
Capital Expenditures	-1.93M	-2.46M	-1.24M	-1.02M	-294K	-271K	-217K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.93M	-2.46M	-1.24M	-1.02M	-294K	-271K	-217K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	3.13M	731K	379K	-3.16M	14K	-37K
Financial Cash Flow	391.82M	178.96M	120.31M	28.55M	296.04M	14K	11.46M
Net Cash Flow	229.02M	51.98M	49.01M	-34.62M	258.86M	-16.25M	18.29M
Free Cash Flow	-162.8M	-126.97M	-71.3M	-63.17M	-37.19M	-16.27M	6.83M